
Uterine Fibroid Treatment Device Market by Technology (Ablation Techniques, Embolization Techniques, Laparoscopic Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment) - Global Forecast 2024-2030
Description
Uterine Fibroid Treatment Device Market by Technology (Ablation Techniques, Embolization Techniques, Laparoscopic Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment) - Global Forecast 2024-2030
The Uterine Fibroid Treatment Device Market size was estimated at USD 560.39 million in 2023 and expected to reach USD 618.32 million in 2024, at a CAGR 10.43% to reach USD 1,122.36 million by 2030.
Global Uterine Fibroid Treatment Device Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Uterine Fibroid Treatment Device Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Uterine Fibroid Treatment Device Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Uterine Fibroid Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Advanced Surgical Concepts, Boston Scientific Corporation, Conmed Corporation, Coopersurgical Inc., Gynesonics, Inc., Hologic, Inc., Insightec Ltd., Karl Storz SE & Co. KG, Medtronic PLC, Merit Medical Systems, Inc., Minerva Surgical, Inc., Olympus Corporation, Pentax Medical, Smith & Nephew PLC, and Stryker Corporation.
Market Segmentation & Coverage
This research report categorizes the Uterine Fibroid Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:
Technology
Ablation Techniques
Cryoablation
Hydrothermal Ablation
Microwave Ablation
Ultrasound Ablation
High Intensity Focused Ultrasound
MRI-Guided Focused Ultrasound
Embolization Techniques
Laparoscopic Techniques
Laparoscopic Myomectomy
Myolysis
Surgical Techniques
Hysterectomy
Myomectomy
Mode of Treatment
Invasive Treatment
Minimally Invasive Treatment
Non-Invasive Treatment
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Uterine Fibroid Treatment Device Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Uterine Fibroid Treatment Device Market?
3. What are the technology trends and regulatory frameworks in the Uterine Fibroid Treatment Device Market?
4. What is the market share of the leading vendors in the Uterine Fibroid Treatment Device Market?
5. Which modes and strategic moves are suitable for entering the Uterine Fibroid Treatment Device Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
197 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Uterine Fibroid Treatment Device Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing occurrence of uterine fibroid worldwide
- 5.1.1.2. Growing penchant for minimally invasive devices
- 5.1.1.3. Rising utilization of technologically advanced products
- 5.1.2. Restraints
- 5.1.2.1. Shortage of required infrastructure in developing economies
- 5.1.3. Opportunities
- 5.1.3.1. Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
- 5.1.3.2. Introduction and development of technologically advanced products
- 5.1.4. Challenges
- 5.1.4.1. Reduced awareness of the device among population
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Uterine Fibroid Treatment Device Market, by Technology
- 6.1. Introduction
- 6.2. Ablation Techniques
- 6.3.1. Cryoablation
- 6.3.2. Hydrothermal Ablation
- 6.3.3. Microwave Ablation
- 6.3.4. Ultrasound Ablation
- 6.3.5.1. High Intensity Focused Ultrasound
- 6.3.5.2. MRI-Guided Focused Ultrasound
- 6.3. Embolization Techniques
- 6.4. Laparoscopic Techniques
- 6.5.1. Laparoscopic Myomectomy
- 6.5.2. Myolysis
- 6.5. Surgical Techniques
- 6.6.1. Hysterectomy
- 6.6.2. Myomectomy
- 7. Uterine Fibroid Treatment Device Market, by Mode of Treatment
- 7.1. Introduction
- 7.2. Invasive Treatment
- 7.3. Minimally Invasive Treatment
- 7.4. Non-Invasive Treatment
- 8. Americas Uterine Fibroid Treatment Device Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Uterine Fibroid Treatment Device Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Uterine Fibroid Treatment Device Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Advanced Surgical Concepts
- 12.1.2. Boston Scientific Corporation
- 12.1.3. Conmed Corporation
- 12.1.4. Coopersurgical Inc.
- 12.1.5. Gynesonics, Inc.
- 12.1.6. Hologic, Inc.
- 12.1.7. Insightec Ltd.
- 12.1.8. Karl Storz SE & Co. KG
- 12.1.9. Medtronic PLC
- 12.1.10. Merit Medical Systems, Inc.
- 12.1.11. Minerva Surgical, Inc.
- 12.1.12. Olympus Corporation
- 12.1.13. Pentax Medical
- 12.1.14. Smith & Nephew PLC
- 12.1.15. Stryker Corporation
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. UTERINE FIBROID TREATMENT DEVICE MARKET RESEARCH PROCESS
- FIGURE 2. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
- FIGURE 3. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. UTERINE FIBROID TREATMENT DEVICE MARKET DYNAMICS
- FIGURE 7. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 8. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2030 (%)
- FIGURE 10. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.